Morningstar Investor users sign in here.

Company Profile

  • Business description

    Invex Therapeutics Ltd is a biopharmaceutical company, focused on the research and development of Exenatide as a treatment for neurological conditions such as Idiopathic Intracranial Hypertension (IIH), traumatic brain injury, or acute stroke. Its other program under development is Presendin which can be used for disabling headaches and permanent vision loss in females. Geographically, it operates only in Australia.

  • Contact

    38 Rowland Street
    Level 1
    Subiaco WA 6008
    AUS

    T: +61 863820137

    https://www.invextherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2024

    Employees

Stocks News & Analysis

stocks

Kogan grappling with muted consumer demand

Sales growth misses our expectations and we downgrade our earnings outlook for 2024 and 2025.
stocks

Tesla earnings plunge and shares surge

Our long-term thesis remains the same for the shares of the electric vehicle giant.
stocks

Are you an investment historian or a futurist?

Each approach has its advantages—and drawbacks.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,837.40 100.10 -1.26%
CAC 40 8,088.24 71.59 0.89%
DAX 40 18,161.01 243.73 1.36%
Dow JONES (US) 38,282.24 196.44 0.52%
FTSE 100 8,139.83 60.97 0.75%
HKSE 17,651.15 366.61 2.12%
NASDAQ 15,954.63 342.88 2.20%
Nikkei 225 37,934.76 306.28 0.81%
NZX 50 Index 11,805.09 141.34 -1.18%
S&P 500 5,108.33 59.91 1.19%
S&P/ASX 200 7,575.90 107.10 -1.39%
SSE Composite Index 3,088.64 35.74 1.17%

Market Movers

Name
Last price
Change
% Change
Sayona Mining Ltd SYA 0.03 0.00 -2.94%
The Star Entertainment Group Ltd SGR 0.39 0.01 -2.50%
South32 Ltd S32 3.37 0.06 1.81%
Tietto Minerals Ltd TIE 0.68 0.00 0.00%
Imugene Ltd IMU 0.08 0.00 -4.82%
BHP Group Ltd BHP 43.15 2.08 -4.60%
Jupiter Mines Ltd JMS 0.30 0.01 1.69%
Red 5 Ltd RED 0.44 0.01 2.33%
Telstra Group Ltd TLS 3.64 0.03 -0.82%
Pilbara Minerals Ltd PLS 3.80 0.06 -1.55%